July - 2021
| Previous Past Months | Showing Journal 2 of 2 |
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19R Caricchio, A Abbate, I Gordeev et al for the CAN-COVID Investigators JAMA, 2021, 326(3):230-239 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
July |
Previous Comments
No Comments yet.
Comment
This trial, on behalf od the CAN-COVID Investigators, examines the effect of the anti–interleukin-1β antibody canakinumab, in hospitalized patients with COVID-19 and “hyperinflammation”.
The authors build clear argument for investigating this agent...